Dinh:Thesis Overview: Difference between revisions
Jump to navigation
Jump to search
>Dinh mNo edit summary |
>Dinh |
||
Line 9: | Line 9: | ||
===Samples: Data generation === | ===Samples: Data generation === | ||
* ''' Early definitive endoderm differentiation (Song's 3-days protocol)''' | * ''' Early definitive endoderm differentiation (Song's 3-days protocol)''' | ||
{| class="wikitable" | |||
| align="center" style="background:#f0f0f0;"|'''Tube ID''' | | align="center" style="background:#f0f0f0;"|'''Tube ID''' | ||
| align="center" style="background:#f0f0f0;"|'''Sample''' | | align="center" style="background:#f0f0f0;"|'''Sample''' |
Revision as of 17:03, 13 March 2015
Samples: Data analysis
- Salk's Human Tissues Whole Genome Bisulfite Sequencing '
- Paper: Not out yet
- Human peripheral mononuclear cells trio - type 2 diabetes - father, mother, daughter
- Human whole blood DNA methylation study - newborn, middle-age, centarian
Samples: Data generation
- Early definitive endoderm differentiation (Song's 3-days protocol)
Tube ID | Sample | Concentration (QUBIT, ng/ul) |
MA-16 | H1 p54 Control TeSR | 57.0 |
MA-17 | H1 p54 Activin-A | 40.1 |
AP-13 | H1 p47 Control TeSR | 85.0 |
AP-14 | H1 p47 BMP-4 | 49.4 |
ESCd0.1 | Day 0 ESCs | 40.3 |
ESCd0.2 | Day 0 ESCs | 56.0 |
ESCd0.3 | Day 0 ESCs | 86.0 |
DE-d3.1 | Day 3 definitive endoderm | 34.0 |
DE-d3.2 | Day 3 definitive endoderm | 37.7 |
DE-d3.3 | Day 3 definitive endoderm | 25.7 |
NaiveESC.1 | naïve ESCs cells | 26.3 |
NaiveESC.2 | naïve ESCs cells | 30.0 |
- 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)
- K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)